ABVC BioPharma, Inc.
ABVC
$0.742
-$0.1725-18.86%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 94.38% | 55.26% | -115.66% | 36.04% | 10.46% |
| Total Depreciation and Amortization | -6.67% | 90.00% | -80.00% | 18.75% | 15.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -82.62% | 13.57% | 987.51% | -1.92% | 135.82% |
| Change in Net Operating Assets | 600.00% | -152.23% | 930.60% | -111.38% | -99.92% |
| Cash from Operations | 112.64% | -12.70% | 68.40% | -3.99% | -164.53% |
| Capital Expenditure | -- | -- | -- | 100.00% | -381.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 285.34% | 96.54% |
| Cash from Investing | -- | -- | -- | 285.11% | 95.15% |
| Total Debt Issued | 100.00% | 100.00% | -91.20% | -- | -620.71% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.79% | -- | -- | -- | 314.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -- | -- | -- | -- |
| Cash from Financing | -108.78% | 2,848.42% | -69.36% | 134.48% | 174.48% |
| Foreign Exchange rate Adjustments | -99.48% | -28.86% | 15.54% | -175.80% | 179.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -92.84% | 107.98% | -114.44% | 30.12% | 123.25% |
